News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VC-Backed Biotech IPOs: Valuations And Virtuous Cycles



8/4/2014 6:36:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

As everyone in biotech knows, the last eighteen months have been an unprecedented time in the public capital markets. 2014 is on track to become the best year ever for life science IPOs, topping both 2013 and 2000. Last week was the busiest single week – with eight IPOs – since February 2000. Over 120 life science companies have gone public since the beginning of last year. This staggering volume of deals has brought nearly $10B of public equity financing to emerging life science players, at attractive prices, which serves as much-needed growth capital to advance their pipelines.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES